A multimodal immuno-radiologic model integrating circulating sPD-L1/CXCL9 and spectral CT iodine metrics to stratify postoperative relapse risk in non-small cell lung cancer
Keyang Zhou, Yang Bai, Lingling Deng, Ting Xie
Springer Nature ·
2026-04-16
· DOI 10.1186/s12885-026-16002-5
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Keyang Zhou, Yang Bai, Lingling Deng, Ting Xie. A multimodal immuno-radiologic model integrating circulating sPD-L1/CXCL9 and spectral CT iodine metrics to stratify postoperative relapse risk in non-small cell lung cancer. // BMC Cancer. – 2026. – DOI: 10.1186/s12885-026-16002-5. – URL: https://doi.org/10.1186/s12885-026-16002-5
Keyang Zhou, Yang Bai, Lingling Deng, & Ting Xie (2026). A multimodal immuno-radiologic model integrating circulating sPD-L1/CXCL9 and spectral CT iodine metrics to stratify postoperative relapse risk in non-small cell lung cancer. BMC Cancer. https://doi.org/10.1186/s12885-026-16002-5
Keyang Zhou, et al. “A multimodal immuno-radiologic model integrating circulating sPD-L1/CXCL9 and spectral CT iodine metrics to stratify postoperative relapse risk in non-small cell lung cancer.” BMC Cancer, 2026. doi:10.1186/s12885-026-16002-5.
@article{Zhou2026,
title = {A multimodal immuno-radiologic model integrating circulating sPD-L1/CXCL9 and spectral CT iodine metrics to stratify postoperative relapse risk in non-small cell lung cancer},
author = {Zhou, Keyang and Bai, Yang and Deng, Lingling and Xie, Ting},
journal = {BMC Cancer},
year = {2026},
doi = {10.1186/s12885-026-16002-5},
url = {https://doi.org/10.1186/s12885-026-16002-5}
}